Ozempic Cost 2026: Price With and Without Insurance

Ozempic costs $349 a month without insurance for the 0.25, 0.5 or 1 mg pen and $499 a month for the 2 mg pen when bought through NovoCare Pharmacy, Novo Nordisk's own self-pay pharmacy, as of October 14, 2026. New patients pay $199 a month for their first two fills at 0.25 or 0.5 mg, an offer dated to end on December 31, 2026. The list price, the starting point for insurers and retail pharmacies, is $1,027.51 per pen, and one pen lasts about a month. With commercial insurance that covers Ozempic, the manufacturer savings offer can bring your cost to as little as $25 a month. Medicare Part D and Medicaid generally cover it for type 2 diabetes. Uninsured people with low incomes may qualify to get it free through Novo Nordisk's Patient Assistance Program.

What you actually pay depends on three things: whether you have type 2 diabetes (the condition Ozempic is approved for), what kind of coverage you have, and your dose. This page works through each case for Ozempic specifically. For the cash prices of every GLP-1 drug side by side, see GLP-1 cost without insurance.

Ozempic prices by pen, October 2026

Pen	Doses per pen	List price	NovoCare self-pay
0.25 mg / 0.5 mg pen (2 mg in 3 mL)	Starter: four 0.25 mg doses plus two 0.5 mg doses; or four 0.5 mg doses	$1,027.51	$199 for the first two fills (new patients, through Dec. 31, 2026), then $349
1 mg pen (4 mg in 3 mL)	Four 1 mg doses	$1,027.51	$349
2 mg pen (8 mg in 3 mL)	Four 2 mg doses	$1,027.51	$499
Ozempic tablets 1.5 mg (30 tablets)	30 daily doses	$1,027.51	Announced at $149
Ozempic tablets 4 mg	30 daily doses	$1,027.51	Announced at $199
Ozempic tablets 9 mg	30 daily doses	$1,027.51	Announced at $299

Sources: NovoCare and NovoCare Pharmacy, checked October 14, 2026; pen contents from the FDA label. Tablet prices are those Novo Nordisk announced at launch on May 1, 2026; NovoCare currently describes them as starting at $149. Pens come with the needles for their doses.

The list price is the same for every strength, because you are paying for a pen that holds a month of doses, not for milligrams. The self-pay prices break that pattern: the 2 mg pen costs $150 more. One oddity follows. Wegovy, the weight-management brand of the same drug, is $349 a month at its 2.4 mg maintenance dose through the same pharmacy, so a cash payer gets more semaglutide for less money than with Ozempic 2 mg. The two are approved for different conditions, though, and are not interchangeable without a new prescription; see Ozempic vs Wegovy.

Cost per week, month and year

A "month" here means one pen, which holds four weekly doses. Because a year has 52 weeks, a full year of injections takes 13 pens, not 12.

Price basis	Per week	Per pen (4 weeks)	Per year (13 pens)
List price, any strength	$256.88	$1,027.51	$13,357.63
Self-pay, 0.25 to 1 mg	$87.25	$349	$4,537 (no intro offer)
Self-pay, 2 mg	$124.75	$499	$6,487 (no intro offer)
Commercial insurance with savings offer	From $6.25	From $25	From $325

What the first year costs a cash payer

Treatment starts at 0.25 mg for four weeks, moves to 0.5 mg, and may go to 1 mg and then 2 mg, each after at least four weeks. These examples assume a new patient paying cash through NovoCare Pharmacy who uses the $199 offer for the first two fills.

Path	How the fills break down	First 12 fills	Full year (13 fills)
Stays at 0.5 mg	2 at $199, then $349	$3,888	$4,237
Moves to 1 mg	2 at $199, then $349	$3,888	$4,237
Moves to 2 mg as fast as the label allows	2 at $199, 1 at $349, then $499	$5,238	$5,737
Ozempic tablets, settles on 4 mg	$149, then $199	$2,338	n/a (30-day fills)
Ozempic tablets, moves to 9 mg	$149, $199, then $299	$3,338	n/a
Any pen at list price	$1,027.51 each	$12,330	$13,358

The first three months on the pen cost $747 at self-pay prices ($199, $199, $349), against about $3,083 at list price. None of these figures include clinician visits, telehealth fees or lab work.

With commercial insurance

Most employer and individual plans cover Ozempic for type 2 diabetes, usually with prior authorization confirming the diagnosis. Your cost is your plan's copay or coinsurance, which the manufacturer savings offer can reduce.

• Savings offer: eligible patients with commercial coverage for Ozempic can pay as little as $25 a month, with savings capped at $100 a month. Example: if your copay is $60, you pay $25; if your coinsurance comes to $180, the offer takes off $100 and you pay $80.
• Who cannot use it: anyone with Medicare, Medicaid, TRICARE, VA or other government coverage. Savings cards cannot be combined with government insurance.
• High-deductible plans: until you meet your deductible, you may owe the plan's negotiated price, which can be higher than the $349 self-pay price. Ask the pharmacy to quote both. Note that cash purchases outside your plan usually do not count toward your deductible or out-of-pocket maximum.
• HSA and FSA: funds can generally be used for prescription drugs, including Ozempic, when prescribed to treat a medical condition. Keep the receipt.

If your plan denies coverage

1. Ask why. The most common reasons are missing prior authorization, a step-therapy rule (for example, try metformin first) or a formulary that prefers a different GLP-1 drug.
2. Ask your prescriber to submit or resubmit prior authorization with your diagnosis, A1C history and the medicines you have already tried.
3. If it is denied again, file an appeal. Plans must tell you how, and you can request an external review by an independent reviewer if the internal appeal fails.
4. Check the formulary for a covered alternative. A preferred GLP-1 at a lower tier can cost far less than any cash price.
5. In the meantime, compare the self-pay price with the plan price for a month or two.

Is Ozempic covered for weight loss?

Rarely. Ozempic is approved for type 2 diabetes, and prior authorization forms ask for that diagnosis. Without it, most plans will deny the claim. A doctor can still prescribe Ozempic off-label, but you will pay the self-pay price. If weight management is the goal, ask whether your plan covers Wegovy or another drug approved for that use, and see Ozempic for weight loss.

With Medicare

Medicare Part D and Medicare Advantage drug plans generally cover Ozempic for type 2 diabetes, often with prior authorization. Under federal law, Part D plans cannot pay for drugs used for weight loss alone, so off-label use for weight is not covered.

• What you pay in 2026: no Part D plan may have a deductible above $615. After the deductible you pay coinsurance, typically 25%, until your out-of-pocket spending on covered drugs reaches $2,100 for the year; after that you pay nothing for covered Part D drugs for the rest of 2026.
• Spreading the cost: the Medicare Prescription Payment Plan lets you pay your out-of-pocket drug costs in monthly amounts across the year. It does not lower the total.
• Extra Help: this program lowers drug costs for people with limited income; you qualify automatically if you have Medicaid, a Medicare Savings Program or SSI.
• Savings cards: cannot be used with Medicare.
• The GLP-1 Bridge does not include Ozempic. Medicare's $50-a-month GLP-1 Bridge, running from July 1, 2026 through December 31, 2027, covers weight-management drugs (Wegovy injection and tablets, Foundayo and the Zepbound KwikPen). It excludes people with type 2 diabetes, whose Part D plan may cover a GLP-1 for diabetes instead.
• 2027: Medicare's negotiated price for semaglutide products (Ozempic, Rybelsus, Wegovy), reported at $274 for a 30-day supply, takes effect January 1, 2027. That is what plans pay, not your copay, but it should lower coinsurance for many enrollees.

With Medicaid, TRICARE or VA

State Medicaid programs generally cover Ozempic for type 2 diabetes, often with prior authorization and sometimes after another drug has been tried first. Copays are low and set by each state. Coverage for weight loss varies by state and is often excluded. TRICARE and the VA each have their own formularies and criteria; manufacturer savings cards cannot be used with either.

Free Ozempic: the Patient Assistance Program

Novo Nordisk's Patient Assistance Program (PAP) provides Ozempic at no cost to some people who could not otherwise afford it. According to NovoCare's 2026 rules:

• you must be a U.S. citizen or legal resident;
• for Ozempic, you must be uninsured with household income at or below 200% of the federal poverty level;
• people with private or commercial insurance are not eligible;
• Medicare enrollees with drug coverage are no longer eligible for Ozempic through the PAP, because most Medicare plans cover it;
• you cannot be enrolled in or eligible for Medicaid, Extra Help or VA benefits; uninsured applicants whose income meets their state's Medicaid limit must show a denial letter;
• Ozempic 0.5 mg, 1 mg and 2 mg are listed.

Approved patients receive the medicine free, with no fees and free shipping to their home; uninsured patients are enrolled for 12 months. You and your prescriber complete the application online at NovoCare, and complete applications are processed within about two business days. The program's number is 1-866-310-7549. Community health centers and hospital financial counselors can also help with applications.

Why the price differs between pharmacies

• List price versus negotiated price. Retail pharmacies start from the list price; your insurer's negotiated price is usually lower but is not visible until you fill.
• Self-pay channel. NovoCare Pharmacy sells at fixed self-pay prices and ships to your home. Some retail and telehealth partners pass the same price through, sometimes with a membership or visit fee.
• Price comparison sites. TrumpRx.gov, a federal comparison site, lists the manufacturers' cash offers; it showed Ozempic from $199 when checked for this guide. You cannot buy from the site itself.
• Discount cards. Commercial discount cards may beat the list price at a retail counter but rarely beat the manufacturer's self-pay price for a brand-name pen.
• Stock. The national semaglutide shortage ended on February 21, 2025, but an individual pharmacy may still need to order your strength.

"Cheap Ozempic": why the low prices have a catch

Ads for semaglutide at $99 to $200 a month are usually for compounded semaglutide, made by compounding pharmacies rather than Novo Nordisk. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before sale. The shortage that allowed near-copies of Ozempic ended on February 21, 2025. On February 6, 2026, the FDA said it intends to act against mass-marketed compounded GLP-1 products, and on April 30, 2026, it proposed keeping semaglutide off the list of bulk substances that outsourcing facilities may use. There is no approved generic Ozempic in the United States.

Products sold as "Ozempic soft," capsules, drops or patches for a few dollars are not semaglutide at all; see Ozempic pill and Ozempic patch. And pens offered without a prescription, on social media or through classified listings, may be counterfeit. Counterfeit Ozempic has been found in the U.S. supply chain.

Ten legitimate ways to pay less

1. Check your formulary first. A covered drug almost always beats a cash price.
2. Get prior authorization done right, and appeal a denial with your A1C history and prior treatments.
3. Activate the savings offer if you have commercial insurance.
4. Compare plan and cash prices while you are in a deductible.
5. Use NovoCare Pharmacy for cash purchases, and claim the $199 introductory price if you are new.
6. Ask whether a lower dose is enough. 0.5 mg and 1 mg cost $150 a month less than 2 mg at self-pay prices; staying at a dose that controls your blood sugar is legitimate and common.
7. Ask about the tablets. Ozempic tablets at 4 mg were announced at $199 a month.
8. On Medicare, ask about Extra Help and the Prescription Payment Plan, and budget around the $2,100 annual cap.
9. If you are uninsured with low income, apply to the Patient Assistance Program.
10. Use HSA or FSA funds for the cost that remains.

How to check the current price yourself

• NovoCare: the self-pay prices, savings offer terms and the list-price explanation.
• Your insurer: the formulary, tier and prior authorization rules, by phone or in the member portal.
• Medicare Plan Finder: on Medicare.gov, to compare what different Part D plans charge for Ozempic.
• Your pharmacist: the final amount with your coverage applied.

Prices in this market have changed several times since 2025. The $199 offer ends December 31, 2026 unless extended, and the Medicare-negotiated price starts January 1, 2027. We will update this page as terms change. For the drug itself, see the Ozempic guide; for dosing and pen use, Ozempic dosage; for getting a prescription, how to get Ozempic. Decisions about treatment belong with your prescriber.